TY - JOUR
T1 - TGFβ signaling activated by cancer-associated fibroblasts determines the histological signature of lung adenocarcinoma
AU - Sato, Ryo
AU - Imamura, Kosuke
AU - Semba, Takashi
AU - Tomita, Yusuke
AU - Saeki, Sho
AU - Ikeda, Koei
AU - Komohara, Yoshihiro
AU - Suzuki, Makoto
AU - Sakagami, Takuro
AU - Saya, Hideyuki
AU - Arima, Yoshimi
N1 - Funding Information:
This work was supported by Japan Society for the Promotion of Science KAKENHI grants 17H06971 and 19K17677 (to R. Sato) by Translational Research Network Program, Research on Applying Health Technology, and Research on Rare and Intractable Diseases grants from the Japan Agency for Medical Research and Development (AMED) grant 22130007 (to H. Saya) and by grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 22130007 to H. Saya; KAKENHI 20K08968 to Y. Arima). The authors thank T. Kitamura, H. Seimiya, and E. Batlle for retroviral
Funding Information:
R. Sato reports grants from Japan Society for the Promotion of Science during the conduct of the study. Y. Tomita reports grants from JSPS KAKENHI grant number JP18K15928 and grants from Takeda Science Foundation outside the submitted work. No disclosures were reported by the other authors.
Publisher Copyright:
© 2021 The Authors.
PY - 2021/9/15
Y1 - 2021/9/15
N2 - Invasive lung adenocarcinoma (LADC) can be classified histologically as lepidic, acinar, papillary, micropapillary, or solid. Most LADC tumors manifest several of these histological subtypes, with heterogeneity being related to therapeutic resistance. We report here that in immunodeficient mice, human LADC cells form tumors with distinct histological features, MUC5AC-expressing solid-type or cytokeratin 7 (CK7)-expressing acinar-type tumors, depending on the site of development, and that a solid-to-acinar transition (SAT) could be induced by the tumor microenvironment. The TGFβ-Smad signaling pathway was activated in both tumor and stromal cells of acinar-type tumors. Immortalized cancerassociated fibroblasts (CAF) derived from acinar-type tumors induced SAT in 3D cocultures with LADC cells. Exogenous TGFβ1 or overexpression of an active form of TGFβ1 increased CK7 expression and reduced MUC5AC expression in LADC cells, and knockdown of Tgfb1 mRNA in CAFs attenuated SAT induction. RNA-sequencing analysis suggested that angiogenesis and neutrophil recruitment are associated with SAT in vivo. Our data indicate that CAF-mediated paracrine TGFβ signaling induces remodeling of tumor tissue and determines the histological pattern of LADC, thereby contributing to tumor heterogeneity.
AB - Invasive lung adenocarcinoma (LADC) can be classified histologically as lepidic, acinar, papillary, micropapillary, or solid. Most LADC tumors manifest several of these histological subtypes, with heterogeneity being related to therapeutic resistance. We report here that in immunodeficient mice, human LADC cells form tumors with distinct histological features, MUC5AC-expressing solid-type or cytokeratin 7 (CK7)-expressing acinar-type tumors, depending on the site of development, and that a solid-to-acinar transition (SAT) could be induced by the tumor microenvironment. The TGFβ-Smad signaling pathway was activated in both tumor and stromal cells of acinar-type tumors. Immortalized cancerassociated fibroblasts (CAF) derived from acinar-type tumors induced SAT in 3D cocultures with LADC cells. Exogenous TGFβ1 or overexpression of an active form of TGFβ1 increased CK7 expression and reduced MUC5AC expression in LADC cells, and knockdown of Tgfb1 mRNA in CAFs attenuated SAT induction. RNA-sequencing analysis suggested that angiogenesis and neutrophil recruitment are associated with SAT in vivo. Our data indicate that CAF-mediated paracrine TGFβ signaling induces remodeling of tumor tissue and determines the histological pattern of LADC, thereby contributing to tumor heterogeneity.
UR - http://www.scopus.com/inward/record.url?scp=85114984734&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114984734&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-20-3941
DO - 10.1158/0008-5472.CAN-20-3941
M3 - Article
C2 - 34289987
AN - SCOPUS:85114984734
SN - 0008-5472
VL - 81
SP - 4751
EP - 4765
JO - Cancer Research
JF - Cancer Research
IS - 18
ER -